Brett P. Giroir, the CEO of the Texas A&M Health Science Center, was nominated chairman of an advisory panel comprised of healthcare leaders that will assist the Veterans Access, Choice and Accountability Act of 2014. Giroir will lead the Blue Ribbon Panel, which was selected by The MITRE Corporation.
The Blue Ribbon Panel will conduct a series of independent reviews of how efficiently the Act is being implemented after it is enacted by Congress and signed by President Obama. Giroir is among the 16 members who were chosen by the non-profit organization that works on federally funded research and development centers (FFRDCs).
“The VA assessments are a vital step in ensuring that the hospital care, medical services and other health care processes in VA medical facilities are optimized to deliver the care that our veterans so richly deserve,” said Giroir. “I am honored and humbled to be leading the Choice Act Blue Ribbon Panel, and I look forward to working with all stakeholders, most importantly the veterans themselves, and contributing to this essential endeavor.”
The panel has been created to offer independent and specialized input into best practices concerning the CMS Alliance to Modernize Healthcare (CAMH), including interim assessments, drafts, and integrated final reports of assessments. The main purpose is to guarantee that the recommendations addressed are in the best interests of U.S. veterans.
“As we gather information from the assessments, our work will be enhanced by the leadership of this aptly-named ‘blue ribbon’ panel of experts,” stated the director of biomedical sciences at the MITRE Corporation, Jay J. Schnitzer, MD, PhD. “We are grateful that world-renowned experts like Dr. Giroir have agreed to support this important initiative to help optimize the VA’s ability to serve our nation’s veterans.”
Last October the Secretary of the Department of Veterans Affairs created the CAMH as a program to integrate operational framework and oversee the assessments of health care, medical services, and other processes conducted in VA medical institutions. Giroir will be working in collaboration with the co-chair of the panel, Gail Wilensky, MD, who is a senior fellow of the Project HOPE.
The CEO of the Texas A&M Health Science Center is also the chairman of the Texas Task Force on Infectious Disease Preparedness and Response, which was created last October by Governor Rick Perry with the purpose of preparing and addressing threats of pandemic diseases, such as Ebola. Two months later, the experts of the task force presented a report and recommendation about the capacities of the state of Texas to respond to a pandemic threat, based on their evaluations.
Giroir is a well recognized and distinguished leader in the field of healthcare, and most recently he gave a keynote address at the Texas Healthcare & Bioscience Institute (THBI)’s second annual Statewide Healthcare Policy Summit. The event took place from February 4-5 during the state’s 84th Legislative Session and gathered an impressive collection of national healthcare policy leaders and biotech CEOs to discuss topics like the future of Texas’ economic incentives, healthcare policies impacting the life sciences industry and legislative priorities.
In addition to Giroir, the Blue Ribbon Panel also includes the physician-in-chief at the Massachusetts General Hospital Department of Medicine, Katrina Armstrong, MD, MSCE, the director of DNP Program at the University of North Carolina at Chapel Hill, Debra Barksdale, MD, the 39th surgeon general of the U.S. Army, Ronald R. Blanck, MD, and the professor of psychology and education at the Columbia University, W. Warner Burke.
The president and CEO of the National Quality Forum, Christine K. Cassel, MD, the former vice chief of staff at the U.S. Army, Gen. Peter W. Chiarelli, the former chairman and executive officer at Kaiser Permanente, George Halvorson, the president of the Accordia Global Health Foundation, Robert L. Mallett, the co-chairman of the board of DaVita HealthCare Partners, Robert Margolis, MD, are also members of the panel.
The panel is also includes Del E. Webb professor of Health Innovation at the Arizona State University, George Poste, MD, the president and CEO of the Texas Medical Center, Robert Robbins, the founder and former president and CEO of the California HealthCare Foundation, Mark D. Smith, MD, MBA, the president and CEO of the Geisinger Health System, Glenn D. Steele Jr., MD, PhD, and with the dean of the Jefferson School of Nursing, Beth Ann Swan, PhD, CRNP, FAAN.